Genome-wide interaction study of smoking and bladder cancer risk

Carcinogenesis

Volumn 35, Issue 8, 2014, Pages 1737-1744

  Figueroa, Jonine D ^a   Han, Summer S ^a   Garcia Closas, Montserrat ^b   Baris, Dalsu ^a   Jacobs, Eric J ^c   Kogevinas, Manolis ^d,e,f,g   Schwenn, Molly ^h   Malats, Nuria ⁱ   Johnson, Alison ^j   Purdue, Mark P ^a   Caporaso, Neil ^a   Landi, Maria Teresa ^a   Prokunina Olsson, Ludmila ^a   Wang, Zhaoming ^k   Hutchinson, Amy ^k   Burdette, Laurie ^k   Wheeler, William ^l   Vineis, Paolo ^m   Siddiq, Afshan ^m   Cortessis, Victoria K ⁿ   Kooperberg, Charles ^o   Cussenot, Olivier ^p,at   Benhamou, Simone ^q,r   Prescott, Jennifer ^s,t   Porru, Stefano ^u   Bas Bueno de Mesquita, H ^m,v,w   Trichopoulos, Dimitrios ^t,x,y   Ljungberg, Börje ^z   Clavel Chapelon, Françoise ^aa   Weiderpass, Elisabete ^ab,ac,ad,ae   Krogh, Vittorio ^af   Dorronsoro, Miren ^ag   Travis, Ruth ^ah   Tjønneland, Anne ^ai   Brenan, Paul ^aj   Chang Claude, Jenny ^ak   Riboli, Elio ^m   Conti, David ⁿ   Gago Dominguez, Manuela ^al   Stern, Mariana C ⁿ   Pike, Malcolm C ^am   van den Berg, David ⁿ   Yuan, Jian Min ^an   Hohensee, Chancellor ^o   Rodabough, Rebecca ^o   Cancel Tassin, Geraldine ^p,ao,at   Roupret, Morgan ^p,ao,at   Comperat, Eva ^p,ao,at   Chen, Constance ^t   de Vivo, Immaculata ^s,t   Giovannucci, Edward ^t   Hunter, David J ^s,t,ap   Kraft, Peter ^t   Lindstrom, Sara ^t   Carta, Angela ^u   Pavanello, Sofia ^aq   Arici, Cecilia ^u   Mastrangelo, Giuseppe ^aq   Karagas, Margaret R ^ar   Schned, Alan ^ar   Armenti, Karla R ^as   Monawar Hosain, G M ^as   Haiman, Chris A ⁿ   Fraumeni Jr , Joseph F ^a   Chanock, Stephen J ^a   Chatterjee, Nilanjan ^a   Rothman, Nathaniel ^a   Silverman, Debra T ^a   more..

^a NATIONAL CANCER INSTITUTE   (United States)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^c AMERICAN CANCER SOCIETY   (United States)

^d CENTRE FOR RESEARCH IN ENVIRONMENTAL EPIDEMIOLOGY CREAL   (Spain)

^e INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^f CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^g NATIONAL SCHOOL OF PUBLIC HEALTH   (Greece)

^h Maine Cancer Registry   (United States)

ⁱ Structural Biology and Biocomputing Programme   (Spain)

^j Vermont Cancer Registry   (United States)

^k SAIC FREDERICK INC   (United States)

^l INFORMATION MANAGEMENT SERVICES INC   (United States)

^m IMPERIAL COLLEGE LONDON   (United Kingdom)

ⁿ UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^o USA   (United States)

^p HÔPITAL TENON   (France)

^q FONDATION JEAN DAUSSET CEPH   (France)

^r Gustave Roussy Comprehensive Cancer Institute   (France)

^s BRIGHAM AND WOMEN S HOSPITAL   (United States)

^t HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^u UNIVERSITY OF BRESCIA   (Italy)

^v NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^w UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^x BIOMEDICAL RESEARCH FOUNDATION   (Greece)

^y HELLENIC HEALTH FOUNDATION   (Greece)

^z UMEÅ UNIVERSITY   (Sweden)

^aa CENTRE FOR RESEARCH IN EPIDEMIOLOGY AND POPULATION HEALTH   (France)

^ab UNIVERSITY OF TROMSØ   (Norway)

^ac CANCER REGISTRY OF NORWAY   (Norway)

^ad KAROLINSKA INSTITUTE   (Sweden)

^ae FOLKHÄLSAN RESEARCH CENTER   (Finland)

^af NATIONAL CANCER INSTITUTE   (Italy)

^ag BIODONOSTIA HEALTH RESEARCH INSTITUTE   (Spain)

^ah UNIVERSITY OF OXFORD   (United Kingdom)

^ai DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^aj INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^ak GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^al HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^am MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^an UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^ao SORBONNE UNIVERSITÉ   (France)

^ap BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^aq UNIVERSITY OF PADOVA   (Italy)

^ar DARTMOUTH MEDICAL SCHOOL   (United States)

^as NEW HAMPSHIRE DEPARTMENT OF HEALTH AND HUMAN SERVICES   (United States)

^at CeRePP Group   (France)

more..

Author keywords

Bladder cancer; Gene environment interaction

Indexed keywords

TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FOXF3; UNCLASSIFIED DRUG; TUMOR MARKER;

ACETYLATION; ARTICLE; BLADDER CANCER; CLINICAL EVALUATION; CONFIDENCE INTERVAL; CONTROLLED STUDY; GENE LOCUS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; MAJOR CLINICAL STUDY; NATIONAL HEALTH ORGANIZATION; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; STATISTICAL SIGNIFICANCE; TOBACCO USE; ADULT; CASE CONTROL STUDY; COMPARATIVE STUDY; GENETIC PREDISPOSITION; GENETICS; HUMAN GENOME; META ANALYSIS (TOPIC); PROGNOSIS; RISK FACTOR; URINARY BLADDER NEOPLASMS;

ADULT; CASE-CONTROL STUDIES; GENE-ENVIRONMENT INTERACTION; GENETIC PREDISPOSITION TO DISEASE; GENOME, HUMAN; HUMANS; META-ANALYSIS AS TOPIC; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; RISK FACTORS; SMOKING; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS;

EID: 84903438611     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgu064     Document Type: Article

References (40)

1. Silverman, D.T., et al. (2006) Bladder Cancer. In Fraumeni, J.F., Jr. and Schottenfeld D (ed.), Cancer Epidemiology and Prevention Third Edition. Oxford University Press, New York, NY, pp. 1101-27.
2. Garcia-Closas, M., et al. (2005) NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses. Lancet, 366, 649-59.
3. Wu, X., et al. (2006) Bladder cancer predisposition: a multigenic approach to DNArepair and cell-cycle-control genes. Am J Hum Genet, 78, 464-79.
4. Stern, M.C., et al. (2009) Polymorphisms in DNA repair genes, smoking, and bladder cancer risk: findings from the international consortium of bladder cancer. Cancer Res, 69, 6857-64.
5. Cantor, K.P., et al. (2010) Polymorphisms in GSTT1, GSTZ1, and CYP2E1, disinfection by-products, and risk of bladder cancer in Spain. Environ Health Perspect, 118, 1545-50.
6. Garcia-Closas, M., et al. (2011) A single nucleotide polymorphism tags variation in the arylamine N-acetyltransferase 2 phenotype in populations of European background. Pharmacogenet Genomics, 21, 231-6.
7. Koutros, S., et al. (2011) Hair dye use and risk of bladder cancer in the New England bladder cancer study. Int J Cancer, 129, 2894-904.
8. Moore, L.E., et al. (2011) GSTM1 null and NAT2 slow acetylation genotypes, smoking intensity and bladder cancer risk: results from the New England bladder cancer study and NAT2 meta-analysis. Carcinogenesis, 32, 182-9.
9. Rothman, N., et al. (2007) Commentary: Reflections on G. M. Lower and colleagues' 1979 study associating slow acetylator phenotype with urinary bladder cancer: metaanalysis, historical refinements of the hypothesis, and lessons learned. Int J Epidemiol, 36, 23-8.
10. Kiemeney, L.A., et al. (2008) Sequence variant on 8q24 confers susceptibility to urinary bladder cancer. Nat Genet, 40, 1307-12.
11. Rafnar, T., et al. (2009) Sequence variants at the TERT-CLPTM1L locus associate with many cancer types. Nat Genet, 41, 221-7.
12. Wu, X., et al. (2009) Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer. Nat Genet, 41, 991-5.
13. Rothman, N., et al. (2010) A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci. Nat Genet, 42, 978-84.
14. Garcia-Closas, M., et al. (2011) A genome-wide association study of bladder cancer identifies a new susceptibility locus within SLC14A1, a urea transporter gene on chromosome 18q12.3. Hum Mol Genet, 20, 4282-9.
15. Rafnar, T., et al. (2011) European genome-wide association study identifies SLC14A1 as a new urinary bladder cancer susceptibility gene. Hum Mol Genet, 20, 4268-81.
16. Fu, Y.P., et al. (2012) Common genetic variants in the PSCA gene influence gene expression and bladder cancer risk. Proc Natl Acad Sci U S A, 109, 4974-9.
17. Tang, W., et al. (2012) Mapping of the UGT1A locus identifies an uncommon coding variant that affects mRNA expression and protects from bladder cancer. Hum Mol Genet, 21, 1918-30.
18. Figueroa, J.D., et al. (2013) Genome-wide association study identifies multiple loci associated with bladder cancer risk. Hum Mol Genet.
19. Garcia-Closas, M., et al. (2013) Common Genetic Polymorphisms Modify the Effect of Smoking on Absolute Risk of Bladder Cancer. Cancer Res, 73, 2211-2220.
20. Baris, D., et al. (2009) A case-control study of smoking and bladder cancer risk: emergent patterns over time. J Natl Cancer Inst, 101, 1553-61.
21. Samanic, C., et al. (2006) Smoking and bladder cancer in Spain: effects of tobacco type, timing, environmental tobacco smoke, and gender. Cancer Epidemiol Biomarkers Prev, 15, 1348-54.
22. Rothman, K.J., et al. (2008) Modern Epidemiology. Lippincott Williams & Wilkins, Philadelphia, PA.
23. Piegorsch, W.W., et al. (1994) Non-hierarchical logistic models and case-only designs for assessing susceptibility in population-based case-control studies. Stat Med, 13, 153-62.
24. Umbach, D.M., et al. (1997) Designing and analysing case-control studies to exploit independence of genotype and exposure. Stat Med, 16, 1731-43.
25. Chatterjee, N., et al. (2005) Semiparametric maximum likelihood estimation exploiting gene-environment independence in case-control studies. Biometrika, 92, 399-418.
26. Albert, P.S., et al. (2001) Limitations of the case-only design for identifying geneenvironment interactions. Am J Epidemiol, 154, 687-93.
27. Han, S.S., et al. (2012) Likelihood ratio test for detecting gene (G)-environment (E) interactions under an additive risk model exploiting G-E independence for case-control data. Am J Epidemiol, 176, 1060-7.
28. Gerstein, M.B., et al. (2012) Architecture of the human regulatory network derived from ENCODE data. Nature, 489, 91-100.
29. Ward, L.D., et al. (2012) HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants. Nucleic Acids Res, 40, D930-4.
30. Boyle, A.P., et al. (2012) Annotation of functional variation in personal genomes using RegulomeDB. Genome Res, 22, 1790-7.
31. Ormestad, M., et al. (2006) Foxf1 and Foxf2 control murine gut development by limiting mesenchymal Wnt signaling and promoting extracellular matrix production. Development, 133, 833-43.
32. Cummings, D.E., et al. (1996) Genetically lean mice result from targeted disruption of the RII beta subunit of protein kinase A. Nature, 382, 622-6.
33. Lai, G.Y., et al. (2013) The association between self-reported diabetes and cancer incidence in the NIH-AARP Diet and Health Study. J Clin Endocrinol Metab, 98, E497-502.
34. Koebnick, C., et al. (2008) Body mass index, physical activity, and bladder cancer in a large prospective study. Cancer Epidemiol Biomarkers Prev, 17, 1214-21.
35. Batty, G.D., et al. (2005) Obesity and overweight in relation to organ-specific cancer mortality in London (UK): findings from the original Whitehall study. Int J Obes (Lond), 29, 1267-74.
36. Wolk, A., et al. (2001) A prospective study of obesity and cancer risk (Sweden). Cancer Causes Control, 12, 13-21.
37. Jivan, A., et al. (2009) Radial spoke protein 3 is a mammalian protein kinase Aanchoring protein that binds ERK1/2. J Biol Chem, 284, 29437-45.
38. Sacco, J.C., et al. (2010) Cytochrome b5 and NADH cytochrome b5 reductase: genotypephenotype correlations for hydroxylamine reduction. Pharmacogenet Genomics, 20, 26-37.
39. Kurian, J.R., et al. (2006) Reductive detoxification of arylhydroxylamine carcinogens by human NADH cytochrome b5 reductase and cytochrome b5. Chem Res Toxicol, 19, 1366-73.
40. Lan, Q., et al. (2012) Genome-wide association analysis identifies new lung cancer susceptibility loci in never-smoking women in Asia. Nat Genet, 44, 1330-5.